Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
01 Nov 2024
Update - Proposed issue of securities - ATX
01 Nov 2024
Replacement Prospectus
01 Nov 2024
Amplia Successfully Completes Institutional Offer
31 Oct 2024
Proposed issue of securities - ATX
30 Oct 2024
Proposed issue of securities - ATX
30 Oct 2024
Proposed issue of securities - ATX
30 Oct 2024
Capital Raise Prospectus
30 Oct 2024
Capital Raise Presentation
30 Oct 2024
Amplia to Raise up to $13m for ACCENT and US Trials
30 Oct 2024
Interim Data From Accent Pancreatic Cancer Trial
1
2
3
4
5
6
7
8
Next